Registry of Patients Being Treated With Norditropin, Recombinant Human Growth Hormone
Phase of Trial: Phase IV
Latest Information Update: 17 Apr 2017
At a glance
- Drugs Somatropin (Primary)
- Indications Dwarfism; Growth disorders; Short stature; Somatotropin deficiency
- Focus Therapeutic Use
- Acronyms ANSWER
- Sponsors Novo Nordisk
- 11 Apr 2017 Status changed from recruiting to completed.
- 20 Feb 2017 Planned End Date changed from 31 Dec 2019 to 31 Dec 2020.
- 20 Feb 2017 Planned End Date changed from 1 Dec 2019 to 31 Dec 2019.